
    
      The main outcome will be pain acceptance. Other outcome measures will be global function
      (assessed with the Fibromyalgia Impact Questionnaire, FIQ), cost-effectiveness (evaluated by
      the Client Service Receipt Inventory, CSRI) and electroencephalographic cordance. The
      mediating variables included are anxiety and depression (assessed with the Hospital Anxiety
      and Depression scale, HADS) and pain (measured with an analog visual scale). A psychiatric
      interview will be administered to the participants to diagnose Posttraumatic Stress Disorder.
      Statistical analysis will be carried out for intention to treat, and using the method Last
      Observation Carried Forward. A Repeated Measures Mixed Model will be used to study the main
      outcome. All calculations will be made with two tails and a significance of 0.05.
    
  